Lentiviral vectors incorporating a human elongation factor 1α promoter for the treatment of canine leukocyte adhesion deficiency

Gene Therapy

Volumn 17, Issue 5, 2010, Pages 672-677

  Nelson, E J R ^a   Tuschong, L M ^a   Hunter, M J ^a   Bauer Jr , T R ^a   Burkholder, T H ^b   Hickstein, D D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CLAD; EF1 promoter; Ex vivo gene therapy; Immunodeficiency; Lentiviral vector; Leukocyte adhesion

Indexed keywords

CD11 ANTIGEN; CD18 ANTIGEN; CD34 ANTIGEN; ELONGATION FACTOR 1ALPHA; LENTIVIRUS VECTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CD34 SELECTION; CONTROLLED STUDY; DOG; EPSTEIN BARR VIRUS; EX VIVO GENE TRANSFER; IMMUNE DEFICIENCY; LEUKOCYTE ADHESION DEFICIENCY; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; WHOLE BODY RADIATION;

ANIMALS; ANTIGENS, CD18; ANTIGENS, CD34; BONE MARROW; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; DOGS; GENE THERAPY; GENETIC VECTORS; HUMANS; LENTIVIRUS; LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; NEUTROPHILS; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS, GENETIC; TRANSDUCTION, GENETIC;

ANIMALIA; CANIS FAMILIARIS;

EID: 77952427688     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.7     Document Type: Article

References (19)

1. Trowald-Wigh G, Hakansson L, Johannisson A, Norrgren L, Hard af Segerstad C. Leucocyte adhesion protein deficiency in Irish setter dogs. Vet Immunol Immunopathol 1992; 32: 261-280.
2. Creevy KE, Bauer Jr TR, Tuschong LM, Embree LJ, Colenda L, Cogan K et al. Canine leukocyte adhesion deficiency colony for investigation of novel hematopoietic therapies. Vet Immunol Immunopathol 2003; 94: 11-22.
3. Kijas JM, Bauer Jr TR, Gafvert S, Marklund S, Trowald-Wigh G, Johannisson A et al. A missense mutation in the b2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency. Genomics 1999; 61: 101-107.
4. Bauer Jr TR, Hai M, Tuschong LM, Burkholder TH, Gu YC, Sokolic RA et al. Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy. Blood 2006; 108: 3313-3320.
5. Bauer Jr TR, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med 2008; 14: 93-97.
6. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419.
7. Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006; 12: 401-409.
8. Zychlinski D, Schambach A, Modlich U, Maetzig T, Meyer J, Grassman E et al. Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol Ther 2008; 16: 718-725.
9. Kim DW, Uetsuki T, Kaziro Y, Yamaguchi N, Sugano S. Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 1990; 91: 217-223.
10. Ye ZQ, Qiu P, Burkholder JK, Turner J, Culp J, Roberts T et al. Cytokine transgene expression and promoter usage in primary CD34+ cells using particle-mediated gene delivery. Hum Gene Ther 1998; 9: 2197-2205.
11. Mikkola H, Woods NB, Sjogren M, Helgadottir H, Hamaguchi I, Jacobsen SE et al. Lentivirus gene transfer in murine hemato-poietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells. J Virol 2000; 74: 11911-11918.
12. Ramezani A, Hawley TS, Hawley RG. Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther 2000; 2: 458-469.
13. Salmon P, Kindler V, Ducrey O, Chapuis B, Zubler RH, Trono D. High-level transgene expression in human hemato-poietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 2000; 96: 3392-3398.
14. Taboit-Dameron F, Malassagne B, Viglietta C, Puissant C, Leroux-Coyau M, Chereau C et al. Association of the 5 HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits. Transgenic Res 1999; 8: 223-235.
15. Bauer Jr TR, Miller AD, Hickstein DD. Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope. Blood 1995; 86: 2379-2387.
16. Back AL, Kwok WW, Adam M, Collins SJ, Hickstein DD. Retroviral-mediated gene transfer of the leukocyte integrin CD18 subunit. Biochem Biophys Res Commun 1990; 171: 787-795.
17. Bauer Jr TR, Creevy KE, Gu YC, Tuschong LM, Donahue RE, Metzger ME et al. Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency. Blood 2004; 103: 3582-3589.
18. Gu YC, Bauer TR, Sokolic RA, Hai M, Tuschong LM, Burkholder T et al. Conversion of the severe to the moderate disease pheno-type with donor leukocyte microchimerism in canine leukocyte adhesion deficiency. Bone Marrow Transplant 2006; 37: 607-614.
19. Chang AH, Stephan MT, Sadelain M. Stem cell-derived erythroid cells mediate long-term systemic protein delivery. Nat Biotechnol 2006; 24: 1017-1021.